Literature DB >> 29452679

Distinct representation of muscle weakness in QMG and MG-ADL.

Robert Henri Pasquale de Meel1, Jan J G M Verschuuren2, Martijn R Tannemaat2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29452679     DOI： 10.1016/S1474-4422(18)30037-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  6 in total

1.  Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.

Authors:  Robert H P de Meel; Carolina Barnett; Vera Bril; Martijn R Tannemaat; Jan J G M Verschuuren
Journal:  J Neuromuscul Dis       Date:  2020

2.  Sensitivity of MG-ADL for generalized weakness in myasthenia gravis.

Authors:  R H P de Meel; W F Raadsheer; E W van Zwet; J J G M Verschuuren; M R Tannemaat
Journal:  Eur J Neurol       Date:  2018-12-17       Impact factor: 6.089

3.  Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature.

Authors:  Robert H P de Meel; Wouter F Raadsheer; Erik W van Zwet; Martijn R Tannemaat; Jan J G M Verschuuren
Journal:  J Neuromuscul Dis       Date:  2019

4.  Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance.

Authors:  Hiroyuki Murai; Shigeaki Suzuki; Miki Hasebe; Yuji Fukamizu; Ema Rodrigues; Kimiaki Utsugisawa
Journal:  Ther Adv Neurol Disord       Date:  2021-03-16       Impact factor: 6.570

5.  Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study.

Authors:  Jinghao Li; Senhui Weng; Sen Lin; Linwen Huang; Xiaojun Yang; Bo Liang; Jiaxin Lu; Qilong Jiang
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

Review 6.  Different Monoclonal Antibodies in Myasthenia Gravis: A Bayesian Network Meta-Analysis.

Authors:  Zhaoming Song; Jie Zhang; Jiahao Meng; Guannan Jiang; Zeya Yan; Yanbo Yang; Zhouqing Chen; Wanchun You; Zhong Wang; Gang Chen
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.